4 Pharmacokinetics
metabolism excretion
Drug metabolism
Phase 1
CYP belongs to a family of haem-containing enzymes and is the major catalyst of drug biotransformation involving oxidative and reductive reactions. It has evolved to biotransform a wide variety of environmental chemicals, food toxins and drugs (Fig. 3.4.1). Oxidation requires NADPH.
Phase 2
These reactions involve the formation of a covalent link between an exposed functional group on a parent compound with glucuronic acid, sulphate, glutathione, amino acids or acetate. This conjugation process results in a highly polar water-soluble metabolite, which is generally inactive and rapidly excreted into the urine or faeces (Fig. 3.4.1).
Only gold members can continue reading. Log In or Register a > to continue